Preparater omfattende dårlig vannløselige farmasøytiske midler og antimikrobielle midler

Provided herein is a dry composition comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in the composition is 18:1 or less, and wherein the weight ratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yang, Andrew, Soon-Shiong, Patrick M. D, Selvaraj, Ray, Desai, Neil, P
Format: Patent
Sprache:nor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Yang, Andrew
Soon-Shiong, Patrick M. D
Selvaraj, Ray
Desai, Neil, P
description Provided herein is a dry composition comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in the composition is 18:1 or less, and wherein the weight ratio of sucrose to the poorly water soluble pharmaceutical agent in the composition is 7:1, 8:1, 9:1, 10:1 or more. Also provided herein is a liquid suspension comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in said suspension is 18:1 or less, and wherein the concentration of sucrose in said suspension is greater than 50 mg/ml, or is 50 mg/ml to 100 mg/ml. Uses of said compositions in a method of treating cancer in an individual are also provided.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO20191301A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO20191301A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO20191301A13</originalsourceid><addsrcrecordid>eNrjZIgOKEotSCxKLEktUsjPTUssKUnNS0lVSDm8tCgnM12hLDEvL-fwjuJUICdVIS2xKDex-PCOypLM4uxUhdzMlByQtnSFxLySzNzM7KL8pMzUnByYDA8Da1piTnEqL5TmZlB0cw1x9tBNLciPTy0uSExOzUstiffzNzIwtDQ0NjB0NDQmRg0ALr0-oQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Preparater omfattende dårlig vannløselige farmasøytiske midler og antimikrobielle midler</title><source>esp@cenet</source><creator>Yang, Andrew ; Soon-Shiong, Patrick M. D ; Selvaraj, Ray ; Desai, Neil, P</creator><creatorcontrib>Yang, Andrew ; Soon-Shiong, Patrick M. D ; Selvaraj, Ray ; Desai, Neil, P</creatorcontrib><description>Provided herein is a dry composition comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in the composition is 18:1 or less, and wherein the weight ratio of sucrose to the poorly water soluble pharmaceutical agent in the composition is 7:1, 8:1, 9:1, 10:1 or more. Also provided herein is a liquid suspension comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in said suspension is 18:1 or less, and wherein the concentration of sucrose in said suspension is greater than 50 mg/ml, or is 50 mg/ml to 100 mg/ml. Uses of said compositions in a method of treating cancer in an individual are also provided.</description><language>nor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080513&amp;DB=EPODOC&amp;CC=NO&amp;NR=20191301A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080513&amp;DB=EPODOC&amp;CC=NO&amp;NR=20191301A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Yang, Andrew</creatorcontrib><creatorcontrib>Soon-Shiong, Patrick M. D</creatorcontrib><creatorcontrib>Selvaraj, Ray</creatorcontrib><creatorcontrib>Desai, Neil, P</creatorcontrib><title>Preparater omfattende dårlig vannløselige farmasøytiske midler og antimikrobielle midler</title><description>Provided herein is a dry composition comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in the composition is 18:1 or less, and wherein the weight ratio of sucrose to the poorly water soluble pharmaceutical agent in the composition is 7:1, 8:1, 9:1, 10:1 or more. Also provided herein is a liquid suspension comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in said suspension is 18:1 or less, and wherein the concentration of sucrose in said suspension is greater than 50 mg/ml, or is 50 mg/ml to 100 mg/ml. Uses of said compositions in a method of treating cancer in an individual are also provided.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIgOKEotSCxKLEktUsjPTUssKUnNS0lVSDm8tCgnM12hLDEvL-fwjuJUICdVIS2xKDex-PCOypLM4uxUhdzMlByQtnSFxLySzNzM7KL8pMzUnByYDA8Da1piTnEqL5TmZlB0cw1x9tBNLciPTy0uSExOzUstiffzNzIwtDQ0NjB0NDQmRg0ALr0-oQ</recordid><startdate>20080513</startdate><enddate>20080513</enddate><creator>Yang, Andrew</creator><creator>Soon-Shiong, Patrick M. D</creator><creator>Selvaraj, Ray</creator><creator>Desai, Neil, P</creator><scope>EVB</scope></search><sort><creationdate>20080513</creationdate><title>Preparater omfattende dårlig vannløselige farmasøytiske midler og antimikrobielle midler</title><author>Yang, Andrew ; Soon-Shiong, Patrick M. D ; Selvaraj, Ray ; Desai, Neil, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO20191301A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2008</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Yang, Andrew</creatorcontrib><creatorcontrib>Soon-Shiong, Patrick M. D</creatorcontrib><creatorcontrib>Selvaraj, Ray</creatorcontrib><creatorcontrib>Desai, Neil, P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Yang, Andrew</au><au>Soon-Shiong, Patrick M. D</au><au>Selvaraj, Ray</au><au>Desai, Neil, P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Preparater omfattende dårlig vannløselige farmasøytiske midler og antimikrobielle midler</title><date>2008-05-13</date><risdate>2008</risdate><abstract>Provided herein is a dry composition comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in the composition is 18:1 or less, and wherein the weight ratio of sucrose to the poorly water soluble pharmaceutical agent in the composition is 7:1, 8:1, 9:1, 10:1 or more. Also provided herein is a liquid suspension comprising (a) nanoparticles comprising a poorly water soluble pharmaceutical agent and albumin, and (b) sucrose, wherein the weight ratio of albumin to the poorly water soluble pharmaceutical agent in said suspension is 18:1 or less, and wherein the concentration of sucrose in said suspension is greater than 50 mg/ml, or is 50 mg/ml to 100 mg/ml. Uses of said compositions in a method of treating cancer in an individual are also provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language nor
recordid cdi_epo_espacenet_NO20191301A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Preparater omfattende dårlig vannløselige farmasøytiske midler og antimikrobielle midler
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A56%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Yang,%20Andrew&rft.date=2008-05-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO20191301A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true